Injective (INJ) is currently priced at $3.24, reflecting a slight increase of 0.93% over the last 24 hours. The daily trading range has been tight, with a high of $3.34 and a low of $3.17, indicating a stable market environment.

The volume stands at approximately 43.41 million, translating to a volume-to-market cap ratio of 13.39%, which suggests moderate trading activity relative to its market capitalization. The hourly moving averages show mixed signals, with the 8 SMA and 55 SMA indicating slight bearish trends, while the 21 SMA suggests minor bullish momentum.

Short-term momentum indicators like the 1-hour RSI at 55 and the 7-day RSI at 53 indicate that INJ is neither overbought nor oversold, positioning it in a neutral zone for potential entry points. The 7-day, 14-day, and 30-day price changes of approximately 10.93%, 17.07%, and 5.20% respectively highlight a positive short- to medium-term trend.

Despite the current price being significantly lower than its all-time high of $52.62 reached in March 2024, the recent price action suggests a recovery phase following previous declines. The technical indicators are showing signs of potential consolidation around the current price level, reflecting market participants’ indecision.

Given the current price level, the mixed moving average signals, and the stable RSI readings, the overall market sentiment for INJ appears cautiously optimistic. Therefore, the recommendation is to Hold, as the asset shows potential for upward movement while maintaining a watchful eye on the evolving technical indicators.